Research

Energy balance

Current clinical evidence does not demonstrate therapeutic benefit of GLP-1RAs in ALS.

Clinicians should be cautious in prescribing GLP-1RAs for ALS due to lack of evidence.

StrongRefutesmedium confidence
In contrast, available clinical evidence is limited and does not demonstrate therapeutic benefit in ALS.
Mohamed Mohsen Helal et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2026

Why this rating

Based on the review of available clinical evidence.

Source

Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists

Mohamed Mohsen Helal et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2026

DOI 10.1080/21678421.2026.2627901

reviewCited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →